Clinical Trial Update: Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

This is a Phase 3 safety study evaluating switching from oral selexipag to intravenous selexipag in patients with stable pulmonary arterial hypertension. The re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Selexipag (selexipag)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2019-05-21